Article History
Received: 19 May 2020
Accepted: 1 June 2020
First Online: 19 June 2020
Compliance with ethical standards
:
: Dr. Ospel reports research scholarships from the Julia Bangerter Rhyner Foundation, University of Basel Research Foundation, Freiwillige Akademische Gesellschaft Basel. Dr. HILL reports grants from Canadian Institutes for Health Research, grants from Alberta Innovates, grants from NoNO Inc., during the conduct of the study; personal fees from Merck, non-financial support from Hoffmann-La Roche Canada Ltd, grants from Covidien (Medtronic), grants from Boehringer-Ingelheim, grants from Stryker Inc., grants from Medtronic LLC, outside the submitted work. In addition, Dr. HILL has a patent Systems and Methods for Assisting in Decision-Making and Triaging for Acute Stroke Patients issued to US Patent office Number: 62/086,077 and owns stock in Pure Web Incorporated, a company that makes, among other products, medical imaging software, is a director of the Canadian Federation of Neurological Sciences, a not-for-profit group, is a director of the Canadian Stroke Consortium, a not-for-profit group, is a director of Circle NeuroVascular Inc., and has received grant support from Alberta Innovates Health Solutions, CIHR, Heart & Stroke Foundation of Canada, National Institutes of Neurological Disorders and Stroke. Dr. Goyal reports personal fees from Medtronic, personal fees from Stryker, personal fees from Microvention, and personal fees from Mentice, outside the submitted work. In addition, Dr. Goyal has a patent Systems of acute stroke diagnosis licensed to GE Healthcare and Principal He was an investigator in the ESCAPE NA1 trial and is a co-author on the DIRECT MT trial manuscript.
: Not applicable.
: Informed consent was obtained from all individual participants included in the studies mentioned in this letter.